Guggenheim lowered the firm’s price target on Universal Health (UHS) to $238 from $262 and keeps a Buy rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UHS:
- Universal Health Sets 2026 Executive Incentive Compensation Framework
- Qualcomm downgraded, Rivian upgraded: Wall Street’s top analyst calls
- Morning News Wrap-Up 3/9/26: Monday’s Biggest Stock Market Stories!
- Midday Fly By: Hims & Hers reaches Novo deal, Live Nation settles with DOJ
- M&A News: Talkspace Stock (TALK) Surges 8% after $835M UHS Acquisition to Keep Tackling U.S. Mental Health Crisis